Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis.
about
The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosisHypoxia and VEGF mRNA expression in human tumorsProliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesionsBevacizumab attenuates hepatic fibrosis in rats by inhibiting activation of hepatic stellate cellsExpression of hypoxia inducible factor-1alpha during liver regeneration induced by partial hepatectomy in ratsHepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosisCycling hypoxia and free radicals regulate angiogenesis and radiotherapy responseHypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic Kupffer cellsHypoxic stress, hepatocytes and CACO-2 viability and susceptibility to Shigella flexneri invasionAquaporin-1 associated with hepatic arterial capillary proliferation on hepatic sinusoid in human cirrhotic liver.Regulation of cholangiocyte proliferation.Intraoperative management of a carbon dioxide embolus in the setting of laparoscopic cholecystectomy for a patient with primary biliary cirrhosis: A case report.Hypoxia-inducible factor-1α regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis.Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-beta-dependent mechanisms.Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytesAngiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease.Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.Hepatic artery and portal vein remodeling in rat liver: vascular response to selective cholangiocyte proliferation.Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cellsHypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice.Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor.Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in ratsCancer stem cell-related factors are associated with the efficacy of pre-operative chemoradiotherapy for locally advanced rectal cancer.Angiogenic cell therapy for hepatic fibrosis.Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitmentThe prognostic role of lactate dehydrogenase serum levels in patients with hepatocellular carcinoma who are treated with sorafenib: the influence of liver fibrosisReduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient miceMicroRNA involvement in hepatocellular carcinoma.Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis.Intrahepatic microcirculatory disorder, parenchymal hypoxia and NOX4 upregulation result in zonal differences in hepatocyte apoptosis following lipopolysaccharide- and D-galactosamine-induced acute liver failure in rats.Role of Hypoxia-Inducible Factors in the Development of Liver Fibrosis.Vascular factors, angiogenesis and biliary tract diseaseProtective effects of silymarin on fumonisin B₁-induced hepatotoxicity in miceParticipation of aquaporin-1 in vascular changes and remodeling in cirrhotic liver.Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab.Angiogenesis in liver regeneration and fibrosis: "a double-edged sword".Difference of polymorphism VEGF-gene rs699947 in Indonesian chronic liver disease population.Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats.Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with MR imaging and angiographically assisted CT.Circulating vascular endothelial growth factor and nitric oxide in patients with liver cirrhosis: A possible association with liver function impairment
P2860
Q26797382-C21E2784-1BD9-4E3E-8BA1-3859335F27ECQ28344471-26BEDE5C-01ED-477C-B71B-EAD924A206FAQ28345280-857A435C-12E8-4449-AEDD-15D2F1785232Q28536257-FBD96BBE-60B7-4F6E-A175-F107357A05F0Q28581724-E8F801F2-ABDE-4ED7-ADCA-23922F15974FQ30316703-53380453-A54E-47C8-A1F6-61BC0BE3522EQ30573416-262B2D7C-04F2-44EF-BDF6-8AF6D280ED21Q33915475-8245F647-D4BF-4601-A0F0-F357E6FD2E34Q33926474-7485B94C-075D-4851-9440-FD41D19E48FDQ34076871-946A281A-3F59-465F-9533-6DB79D7E3A48Q34229378-CAB1BD2C-AF8C-4AAA-AC8B-07FE8F32127EQ34578639-0675D6EF-EEEB-43A4-946A-C5FB6521F855Q34996476-AC1D82F4-E1DC-4B0B-B131-955C440A1966Q35034329-75F2A17D-2DE4-4CB6-921C-247699C56C70Q35034353-E1E63875-7E04-4E89-8C93-1CECBC67E420Q35103148-5583E008-28D6-44AC-A887-DA8F724FBC50Q35747368-06DF5536-D387-4E81-9452-E3A823035091Q35749261-06AEAAE2-303A-4F1E-8F99-1195268BDACCQ35855600-3425468A-48EB-4256-BC27-54CBE019C6DDQ35913174-1BAF952C-9CD2-4076-AEEE-6932B45BB1D3Q36180591-65EF3FD3-AA56-4155-A7E5-F95C64CA0EE6Q36226666-7605436B-452D-402F-A167-D653D2C1757AQ36230733-1F3C7F34-E929-4D0C-B5CC-E0C72A3EF9E0Q36436755-17520251-A157-4184-B751-6C502B8A547DQ36962774-7428F90A-28AC-4446-882A-ADA5CB40DFE7Q37131689-40BE35D4-7DF3-4420-BE20-51D022E78848Q37138759-21B7E199-ABE6-4E63-8EA2-B7B17DC619E9Q37361575-CAB333FA-A801-40AA-9666-E1B11396C003Q37426714-072BF62B-A1BB-46A3-B411-40D207B1D3FCQ37496114-FA17394F-5F92-4E49-AD59-597B1C8886EFQ37635449-623AD1BB-B216-4E10-9900-5B51B2F3E0B9Q37671557-C1CE08E7-95AC-44FA-A2B5-D9BDE79BBDE5Q37681106-95A10FA3-57DD-43D6-AAB1-3C4D4D99C13FQ38095400-C0C4C31F-4728-4D19-B093-1C780A56D71DQ38155097-7D3348C8-02B9-4404-8819-95F77580E71BQ38552296-BFA38CFE-B372-49DF-AADE-4DA8096C090EQ38610074-70691F60-B7A4-4D9C-96C1-0627264FB1F6Q40156805-95071A64-E46F-44BB-A3D3-3BFD2328E6C4Q40368895-8545CD91-E5FC-4559-84BE-86C571BADE47Q41872249-A75AEBBC-CD3A-42CC-B811-DF1A8240A4D0
P2860
Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Hepatocellular hypoxia-induced ...... xperimental biliary cirrhosis.
@ast
Hepatocellular hypoxia-induced ...... xperimental biliary cirrhosis.
@en
type
label
Hepatocellular hypoxia-induced ...... xperimental biliary cirrhosis.
@ast
Hepatocellular hypoxia-induced ...... xperimental biliary cirrhosis.
@en
prefLabel
Hepatocellular hypoxia-induced ...... xperimental biliary cirrhosis.
@ast
Hepatocellular hypoxia-induced ...... xperimental biliary cirrhosis.
@en
P2093
P2860
P921
P1476
Hepatocellular hypoxia-induced ...... xperimental biliary cirrhosis.
@en
P2093
C Corpechot
O Rosmorduc
P2860
P304
P356
10.1016/S0002-9440(10)65209-1
P407
P50
P577
1999-10-01T00:00:00Z